Healthcare PR: Building Trust in a Category Where Every Word Is Regulated

Healthcare PR isn't harder because the audience is harder. It's harder because every claim, every patient story, every executive quote sits inside a regulatory perimeter that other categories don't have.

Patient stories require true consent

A patient testimonial in healthcare PR is not the same asset it is in consumer or B2B. It requires informed, written consent under HIPAA, careful review of what identifying details can appear, and often a legal read before it goes to any outlet. GCPR treats patient-story development as a workflow, not a pitch — with template releases, scope limits, and post-publication removal rights.

Claims discipline

The FDA regulates disease claims. The FTC regulates efficacy claims. Both regulate testimonials that suggest specific outcomes. "Cures," "treats," "reverses," and "eliminates" are almost never appropriate outside of an FDA-cleared context. "Supports," "helps manage," and "designed to" are the language most healthcare comms teams operate in for good reason.

The outlets that matter

STAT News, Endpoints News, Fierce Healthcare, MedCity News, Healthcare Dive, and the health desks at NYT and WaPo drive the industry conversation. For digital-health specifically, Rock Health, Health Tech magazine, and podcasts like Second Opinion move investor attention. Consumer coverage — Well+Good, Self, Prevention — reaches patients, but only after the trade press validates.

The trust dividend

The single most valuable outcome of a well-run healthcare PR program isn't reach — it's trust. Trust is what earns provider partnerships, payer conversations, and eventual acquirer interest. Sloppy PR in healthcare doesn't just underperform; it sets categories back.

Media Contact: GCPR Communications — info@gcprhq.com — www.gcprhq.com

— END —